Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Aug;62(8):3276–3281. doi: 10.1128/iai.62.8.3276-3281.1994

Peptidoglycan fragments decrease food intake and body weight gain in rats.

K J Biberstine 1, R S Rosenthal 1
PMCID: PMC302956  PMID: 8039898

Abstract

We hypothesized that peptidoglycan (PG) fragments decrease appetite in rats. Male Lewis rats (150 g; n > or = 7) received intraperitoneal (i.p.) injections of purified soluble PG fragments that had been treated with polymyxin B-agarose to remove residual endotoxin. Food consumption and body weight gain were determined at intervals after injection. Single i.p. injections of macromolecular extensively O-acetylated PG (S-O-PG) and non-O-acetylated PG fragments (24 to 240 micrograms/kg) reduced food intake and body weight gain in a dose-dependent fashion during the first 12 h after injection. Low-molecular-weight disaccharide peptide monomers with nonreducing 1,6-anhydro-N-acetylmuramic acid ends and muramyl dipeptide (MDP; 1.6 mg/kg) were also appetite and weight gain suppressants, albeit at least 10-fold less potent than S-O-PG; however, muramidase-derived monomers and peptide cross-linked dimers with reducing muramic acid ends were inactive. Appetite suppression was not limited to the Lewis rat strain since another strain, F344, exhibited similar decreases in food intake after injection of S-O-PG or MDP. Oral administration of MDP or S-O-PG, at concentrations 3 and 20 times higher, respectively, than those that were active i.p., failed to elicit a hypophagic response. We conclude that soluble PG fragments are potent suppressants of food consumption and body weight gain in rats and that, although macromolecular PG is more potent than low-molecular-weight fragments, neither O-acetylation nor glycosidic linkage of PG fragments is required for activity. We speculate that PG fragments may contribute to loss of appetite during bacterial illness.

Full text

PDF
3276

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderle S. K., Allen J. B., Wilder R. L., Eisenberg R. A., Cromartie W. J., Schwab J. H. Measurement of streptococcal cell wall in tissues of rats resistant or susceptible to cell wall-induced chronic erosive arthritis. Infect Immun. 1985 Sep;49(3):836–837. doi: 10.1128/iai.49.3.836-837.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bristol L. A., Durum S. K., Eisenberg S. P. Differential regulation of group A streptococcal peptidoglycan-polysaccharide (PG-APS)-stimulated macrophage production of IL-1 by rat strains susceptible and resistant to PG-APS-induced arthritis. Cell Immunol. 1993 Jun;149(1):130–143. doi: 10.1006/cimm.1993.1142. [DOI] [PubMed] [Google Scholar]
  3. Cavaillon J. M., Haeffner-Cavaillon N. Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages. Cytokine. 1990 Sep;2(5):313–329. doi: 10.1016/1043-4666(90)90061-w. [DOI] [PubMed] [Google Scholar]
  4. Curzon G. Serotonin and appetite. Ann N Y Acad Sci. 1990;600:521–531. doi: 10.1111/j.1749-6632.1990.tb16907.x. [DOI] [PubMed] [Google Scholar]
  5. Damais C., Riveau G., Parant M., Gerota J., Chedid L. Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative. Int J Immunopharmacol. 1982;4(5):451–462. doi: 10.1016/0192-0561(82)90020-0. [DOI] [PubMed] [Google Scholar]
  6. Dinarello C. A., Cannon J. G., Wolff S. M., Bernheim H. A., Beutler B., Cerami A., Figari I. S., Palladino M. A., Jr, O'Connor J. V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986 Jun 1;163(6):1433–1450. doi: 10.1084/jem.163.6.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dinarello C. A., Cannon J. G., Wolff S. M. New concepts on the pathogenesis of fever. Rev Infect Dis. 1988 Jan-Feb;10(1):168–189. doi: 10.1093/clinids/10.1.168. [DOI] [PubMed] [Google Scholar]
  8. Dinarello C. A., Elin R. J., Chedid L., Wolff S. M. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J Infect Dis. 1978 Dec;138(6):760–767. doi: 10.1093/infdis/138.6.760. [DOI] [PubMed] [Google Scholar]
  9. Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
  10. Endres S., van der Meer J. W., Dinarello C. A. Interleukin-1 in the pathogenesis of fever. Eur J Clin Invest. 1987 Dec;17(6):469–474. doi: 10.1111/j.1365-2362.1987.tb01144.x. [DOI] [PubMed] [Google Scholar]
  11. Fleming T. J., Wallsmith D. E., Rosenthal R. S. Arthropathic properties of gonococcal peptidoglycan fragments: implications for the pathogenesis of disseminated gonococcal disease. Infect Immun. 1986 May;52(2):600–608. doi: 10.1128/iai.52.2.600-608.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johannsen L. Biological properties of bacterial peptidoglycan. APMIS. 1993 May;101(5):337–344. doi: 10.1111/j.1699-0463.1993.tb00119.x. [DOI] [PubMed] [Google Scholar]
  13. Johannsen L., Rosenthal R. S., Martin S. A., Cady A. B., Obal F., Jr, Guinand M., Krueger J. M. Somnogenic activity of O-acetylated and dimeric muramyl peptides. Infect Immun. 1989 Sep;57(9):2726–2732. doi: 10.1128/iai.57.9.2726-2732.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kapás L., Hong L., Cady A. B., Opp M. R., Postlethwaite A. E., Seyer J. M., Krueger J. M. Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments. Am J Physiol. 1992 Sep;263(3 Pt 2):R708–R715. doi: 10.1152/ajpregu.1992.263.3.R708. [DOI] [PubMed] [Google Scholar]
  15. Kluger M. J. Fever: role of pyrogens and cryogens. Physiol Rev. 1991 Jan;71(1):93–127. doi: 10.1152/physrev.1991.71.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kotani S., Tsujimoto M., Koga T., Nagao S., Tanaka A., Kawata S. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed Proc. 1986 Oct;45(11):2534–2540. [PubMed] [Google Scholar]
  17. Kotani S., Watanabe Y., Kinoshita F., Kato K., Harada K. Gelation of the amoebocyte lysate of Tachypleus tridentatus by cell wall digest of several gram-positive bacteria and synthetic peptidoglycan subunits of natural and unnatural configurations. Biken J. 1977 Mar;20(1):5–10. [PubMed] [Google Scholar]
  18. Krueger J. M., Karnovsky M. L., Martin S. A., Pappenheimer J. R., Walter J., Biemann K. Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination. J Biol Chem. 1984 Oct 25;259(20):12659–12662. [PubMed] [Google Scholar]
  19. Krueger J. M., Kubillus S., Shoham S., Davenne D. Enhancement of slow-wave sleep by endotoxin and lipid A. Am J Physiol. 1986 Sep;251(3 Pt 2):R591–R597. doi: 10.1152/ajpregu.1986.251.3.R591. [DOI] [PubMed] [Google Scholar]
  20. Krueger J. M., Majde J. A. Sleep as a host defense: its regulation by microbial products and cytokines. Clin Immunol Immunopathol. 1990 Nov;57(2):188–199. doi: 10.1016/0090-1229(90)90033-m. [DOI] [PubMed] [Google Scholar]
  21. Krueger J. M., Pappenheimer J. R., Karnovsky M. L. Sleep-promoting effects of muramyl peptides. Proc Natl Acad Sci U S A. 1982 Oct;79(19):6102–6106. doi: 10.1073/pnas.79.19.6102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Krueger J. M., Rosenthal R. S., Martin S. A., Walter J., Davenne D., Shoham S., Kubillus S. L., Biemann K. Bacterial peptidoglycans as modulators of sleep. I. Anhydro forms of muramyl peptides enhance somnogenic potency. Brain Res. 1987 Feb 17;403(2):249–257. doi: 10.1016/0006-8993(87)90062-x. [DOI] [PubMed] [Google Scholar]
  23. Krueger J. M., Walter J., Dinarello C. A., Wolff S. M., Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol. 1984 Jun;246(6 Pt 2):R994–R999. doi: 10.1152/ajpregu.1984.246.6.R994. [DOI] [PubMed] [Google Scholar]
  24. Krueger J. M., Walter J., Karnovsky M. L., Chedid L., Choay J. P., Lefrancier P., Lederer E. Muramyl peptides. Variation of somnogenic activity with structure. J Exp Med. 1984 Jan 1;159(1):68–76. doi: 10.1084/jem.159.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Langhans W., Harlacher R., Balkowski G., Scharrer E. Comparison of the effects of bacterial lipopolysaccharide and muramyl dipeptide on food intake. Physiol Behav. 1990 May;47(5):805–813. doi: 10.1016/0031-9384(90)90001-k. [DOI] [PubMed] [Google Scholar]
  26. Martin S. A., Karnovsky M. L., Krueger J. M., Pappenheimer J. R., Biemann K. Peptidoglycans as promoters of slow-wave sleep. I. Structure of the sleep-promoting factor isolated from human urine. J Biol Chem. 1984 Oct 25;259(20):12652–12658. [PubMed] [Google Scholar]
  27. Masek K., Kadlecová O., Petrovický P. The effect of some bacterial products on temperature and sleep in rat. Z Immunitatsforsch Exp Klin Immunol. 1975 Jul;149(2-4):273–282. [PubMed] [Google Scholar]
  28. McCarthy D. O., Kluger M. J., Vander A. J. Suppression of food intake during infection: is interleukin-1 involved? Am J Clin Nutr. 1985 Dec;42(6):1179–1182. doi: 10.1093/ajcn/42.6.1179. [DOI] [PubMed] [Google Scholar]
  29. McCarthy D. O., Kluger M. J., Vander A. J. The role of fever in appetite suppression after endotoxin administration. Am J Clin Nutr. 1984 Aug;40(2):310–316. doi: 10.1093/ajcn/40.2.310. [DOI] [PubMed] [Google Scholar]
  30. Morrison D. C., Ulevitch R. J. The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol. 1978 Nov;93(2):526–618. [PMC free article] [PubMed] [Google Scholar]
  31. Nagao S., Akagawa K. S., Okada F., Harada Y., Yagawa K., Kato K., Tanigawa Y. Species dependency of in vitro macrophage activation by bacterial peptidoglycans. Microbiol Immunol. 1992;36(11):1155–1171. doi: 10.1111/j.1348-0421.1992.tb02119.x. [DOI] [PubMed] [Google Scholar]
  32. Nakamura H., Seto Y., Motoyoshi S., Kadokawa T., Sunahara N. Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits. J Pharmacol Exp Ther. 1988 Apr;245(1):336–341. [PubMed] [Google Scholar]
  33. Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987 Aug 14;50(4):555–563. doi: 10.1016/0092-8674(87)90028-6. [DOI] [PubMed] [Google Scholar]
  34. Riveau G., Masek K., Parant M., Chedid L. Central pyrogenic activity of muramyl dipeptide. J Exp Med. 1980 Oct 1;152(4):869–877. doi: 10.1084/jem.152.4.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Root-Bernstein R. S., Westall F. C. Serotonin binding sites. II. Muramyl dipeptide binds to serotonin binding sites on myelin basic protein, LHRH, and MSH-ACTH 4-10. Brain Res Bull. 1990 Dec;25(6):827–841. doi: 10.1016/0361-9230(90)90178-3. [DOI] [PubMed] [Google Scholar]
  36. Rosenthal R. S., Dziarski R. Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods Enzymol. 1994;235:253–285. doi: 10.1016/0076-6879(94)35146-5. [DOI] [PubMed] [Google Scholar]
  37. Rosenthal R. S., Folkening W. J., Miller D. R., Swim S. C. Resistance of O-acetylated gonococcal peptidoglycan to human peptidoglycan-degrading enzymes. Infect Immun. 1983 Jun;40(3):903–911. doi: 10.1128/iai.40.3.903-911.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rosenthal R. S. Release of soluble peptidoglycan from growing gonococci: hexaminidase and amidase activities. Infect Immun. 1979 Jun;24(3):869–878. doi: 10.1128/iai.24.3.869-878.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Shoham S., Davenne D., Cady A. B., Dinarello C. A., Krueger J. M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol. 1987 Jul;253(1 Pt 2):R142–R149. doi: 10.1152/ajpregu.1987.253.1.R142. [DOI] [PubMed] [Google Scholar]
  40. Silverman D. H., Imam K., Karnovsky M. L. Muramyl peptide/serotonin receptors in brain-derived preparations. Pept Res. 1989 Sep-Oct;2(5):338–344. [PubMed] [Google Scholar]
  41. Silverman D. H., Krueger J. M., Karnovsky M. L. Specific binding sites for muramyl peptides on murine macrophages. J Immunol. 1986 Mar 15;136(6):2195–2201. [PubMed] [Google Scholar]
  42. Silverman D. H., Wu H., Karnovsky M. L. Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release. Biochem Biophys Res Commun. 1985 Sep 30;131(3):1160–1167. doi: 10.1016/0006-291x(85)90212-8. [DOI] [PubMed] [Google Scholar]
  43. Sinha R. K., Rosenthal R. S. Release of soluble peptidoglycan from growing conococci: demonstration of anhydro-muramyl-containing fragments. Infect Immun. 1980 Sep;29(3):914–925. doi: 10.1128/iai.29.3.914-925.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sternberg E. M., Hill J. M., Chrousos G. P., Kamilaris T., Listwak S. J., Gold P. W., Wilder R. L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2374–2378. doi: 10.1073/pnas.86.7.2374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Swim S. C., Gfell M. A., Wilde C. E., 3rd, Rosenthal R. S. Strain distribution in extents of lysozyme resistance and O-acetylation of gonococcal peptidoglycan determined by high-performance liquid chromatography. Infect Immun. 1983 Nov;42(2):446–452. doi: 10.1128/iai.42.2.446-452.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tracey K. J., Wei H., Manogue K. R., Fong Y., Hesse D. G., Nguyen H. T., Kuo G. C., Beutler B., Cotran R. S., Cerami A. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med. 1988 Mar 1;167(3):1211–1227. doi: 10.1084/jem.167.3.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wauquier A., Dugovic C. Serotonin and sleep-wakefulness. Ann N Y Acad Sci. 1990;600:447–459. doi: 10.1111/j.1749-6632.1990.tb16901.x. [DOI] [PubMed] [Google Scholar]
  48. Wilder R. L., Calandra G. B., Garvin A. J., Wright K. D., Hansen C. T. Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum. 1982 Sep;25(9):1064–1072. doi: 10.1002/art.1780250906. [DOI] [PubMed] [Google Scholar]
  49. van Miert A. S., van Duin C. T., Anika S. M. Anorexia during febrile conditions in dwarf goats. The effect of diazepam, flurbiprofen and naloxone. Vet Q. 1986 Oct;8(4):266–273. doi: 10.1080/01652176.1986.9694055. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES